cremophor el has been researched along with daunorubicin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kessel, D | 1 |
| Chojnowski, G; Kriegler, AB; Linsenmeyer, ME; Nink, V; Sawyer, WH; Webster, LK; Woodcock, DM | 1 |
| Broxterman, HJ; Dekker, H; Lankelma, J; Schuurhuis, GJ; Spoelstra, EC | 1 |
| Demant, EJ; Friche, E; Jensen, PB; Nissen, NN; Sehested, M | 1 |
| Cornblatt, B; Lee, EJ; Levy, C; Ross, DD; Schiffer, CA; Sridhara, R; Tong, Y; Wooten, PJ | 1 |
| Decker, D; Kessel, D; Sykes, E; Woodburn, K | 1 |
| Aszalos, A; Bocsi, J; Ladányi, A; Szende, B | 1 |
7 other study(ies) available for cremophor el and daunorubicin
| Article | Year |
|---|---|
Properties of cremophor EL micelles probed by fluorescence.
Topics: Anilino Naphthalenesulfonates; Animals; Biological Transport; Daunorubicin; Fluorescence Polarization; Fluorescent Dyes; Glycerol; Leukemia P388; Mice; Micelles; Spectrometry, Fluorescence; Surface-Active Agents; Tumor Cells, Cultured | 1992 |
Reversal of multidrug resistance by surfactants.
Topics: Animals; Biological Transport; Bone Marrow; Cell Line; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance; Glycerol; Humans; Leukemia P388; Membrane Fluidity; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Surface-Active Agents; Tumor Cells, Cultured | 1992 |
P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Survival; Colonic Neoplasms; Daunorubicin; Drug Resistance; Female; Glycerol; Humans; Membrane Glycoproteins; Mice; Neoplasm Proteins; Ovarian Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Verapamil | 1991 |
The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Carcinoma, Ehrlich Tumor; Cyclosporins; Daunorubicin; Dihydropyridines; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Glycerol; Humans; Intracellular Membranes; Membrane Glycoproteins; Polysorbates; Tritium; Tumor Cells, Cultured; Verapamil | 1990 |
Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL.
Topics: Cell Survival; Cyclosporine; Daunorubicin; Drug Resistance; Drug Synergism; Female; Glycerol; Humans; Leukemia, Myeloid, Acute; Male; Tumor Cells, Cultured | 1994 |
Fractionation of Cremophor EL delineates components responsible for plasma lipoprotein alterations and multidrug resistance reversal.
Topics: Animals; Antineoplastic Agents; Biological Transport; Chemical Fractionation; Chromatography, High Pressure Liquid; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Electrophoresis, Agar Gel; Electrophoresis, Polyacrylamide Gel; Glycerol; Humans; Leukemia P388; Lipoproteins; Mice; Paclitaxel; Pharmaceutical Vehicles; Protein Binding | 1995 |
Induction of apoptosis in MDR1 expressing cells by daunorubicin with combinations of suboptimal concentrations of P-glycoprotein modulators.
Topics: 3T3 Cells; Animals; Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cyclosporins; Daunorubicin; Drug Combinations; Drug Interactions; G2 Phase; Glycerol; Mice; Verapamil | 2001 |